Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,009 | 146 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $434.15 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $192.76 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $180.74 | 11 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $172.48 | 2 | $0 (2021) |
| Lilly USA, LLC | $163.11 | 10 | $0 (2023) |
| GM Pharmaceuticals, Inc. | $155.66 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $143.66 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $136.15 | 8 | $0 (2024) |
| Amgen Inc. | $133.80 | 8 | $0 (2024) |
| Allergan, Inc. | $89.79 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $318.13 | 15 | REVANCE THERAPEUTICS, INC. ($77.49) |
| 2023 | $224.34 | 10 | ConvaTec Inc. ($55.86) |
| 2022 | $382.53 | 27 | Abbott Laboratories ($246.84) |
| 2021 | $549.11 | 19 | Biohaven Pharmaceuticals, Inc. ($172.48) |
| 2020 | $257.96 | 16 | Allergan, Inc. ($71.11) |
| 2019 | $125.41 | 8 | SANOFI-AVENTIS U.S. LLC ($47.44) |
| 2018 | $617.50 | 22 | GM Pharmaceuticals, Inc. ($155.66) |
| 2017 | $533.88 | 29 | SANOFI-AVENTIS U.S. LLC ($69.03) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Neuromodulation | ||||||
| 09/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Diabetes Care | ||||||
| 08/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $54.63 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/13/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Respiratory | ||||||
| 07/01/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Respiratory | ||||||
| 04/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Bone Health | ||||||
| 03/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Obesity | ||||||
| 02/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 02/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Endocrinology | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Inflammation | ||||||
| 12/04/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 11/07/2023 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2023 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 07/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: PSYCHIATRY | ||||||
| 05/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Diabetes | ||||||
| 04/05/2023 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/06/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Diabetes Care | ||||||
| 02/14/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 1,663 | 4,165 | $623,064 | $240,487 |
| 2022 | 42 | 2,509 | 6,571 | $1.2M | $425,755 |
| 2021 | 29 | 1,841 | 4,323 | $774,652 | $262,757 |
| 2020 | 22 | 1,238 | 1,761 | $656,800 | $162,276 |
All Medicare Procedures & Services
140 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 205 | $69,941 | $29,068 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 221 | $55,917 | $21,019 | 37.6% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 37 | 528 | $37,564 | $18,157 | 48.3% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 58 | 159 | $58,418 | $16,010 | 27.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 43 | 44 | $31,779 | $13,609 | 42.8% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 22 | 562 | $32,564 | $13,170 | 40.4% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 43 | 44 | $21,375 | $9,798 | 45.8% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 55 | 84 | $20,128 | $8,368 | 41.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 29 | 184 | $18,647 | $7,094 | 38.0% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2023 | 44 | 91 | $9,100 | $6,689 | 73.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 29 | 163 | $20,541 | $6,397 | 31.1% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 56 | 57 | $13,505 | $5,956 | 44.1% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 11 | 59 | $14,750 | $5,876 | 39.8% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 33 | 170 | $11,829 | $5,846 | 49.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 54 | 123 | $34,719 | $5,220 | 15.0% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 14 | 138 | $12,899 | $5,186 | 40.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 26 | 161 | $20,160 | $5,123 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $9,145 | $5,092 | 55.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 32 | 33 | $12,314 | $4,848 | 39.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 30 | 31 | $10,347 | $4,812 | 46.5% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 51 | 65 | $10,519 | $4,598 | 43.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 54 | 123 | $16,728 | $4,258 | 25.5% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 42 | 43 | $8,842 | $3,781 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 57 | $10,202 | $3,487 | 34.2% |
| 93979 | Ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 26 | 28 | $5,825 | $2,662 | 45.7% |
About Dr. Karen Thampoe, M.D
Dr. Karen Thampoe, M.D is a Internal Medicine healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750390092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Thampoe, M.D has received a total of $3,009 in payments from pharmaceutical and medical device companies, with $318.13 received in 2024. These payments were reported across 146 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($3,009).
As a Medicare-enrolled provider, Thampoe has provided services to 7,251 Medicare beneficiaries, totaling 16,820 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 140 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Katy, TX
- Active Since 08/05/2006
- Last Updated 07/02/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750390092
Products in Payments
- ENTRESTO (Drug) $192.76
- NURTEC ODT (Drug) $187.03
- FREESTYLE LIBRE 2 (Device) $156.20
- Vanatol S (Drug) $155.66
- TOUJEO (Drug) $117.47
- TRULICITY (Drug) $101.17
- HeartMate 3 Left Ventricular Assist Device (Device) $90.15
- JARDIANCE (Drug) $83.62
- DAXXIFY (Drug) $77.49
- UBRELVY (Drug) $71.11
- Edarbyclor (Drug) $64.04
- PROCLAIM (Device) $63.25
- FARXIGA (Drug) $62.58
- Natesto (Drug) $61.75
- INNOVAMATRIX AC (Device) $55.86
- VYVANSE (Drug) $54.42
- Aimovig (Biological) $52.49
- FREESTYLE LIBRE (Device) $49.92
- MYDAYIS (Drug) $46.23
- XIFAXAN (Drug) $45.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Katy
Dharmendra Verma, M.d, M.D
Internal Medicine — Payments: $43,959
Dr. Syed Zaidi, M.d, M.D
Internal Medicine — Payments: $20,985
Dr. Mukesh Mehta, M.d, M.D
Internal Medicine — Payments: $18,042
Dr. Moo Chung, M.d, M.D
Internal Medicine — Payments: $17,384
Roger Campana, Md, MD
Internal Medicine — Payments: $17,323
Mr. Barry Troyan, Md, MD
Internal Medicine — Payments: $16,038